Roivant Sciences Ltd (NASDAQ: ROIV) is -2.76% lower on its value in year-to-date trading and has touched a low of $6.97 and a high of $13.24 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ROIV stock was last observed hovering at around $10.43 in the last trading session, with the day’s gains setting it 0.49%.
Currently trading at $10.92, the stock is 3.87% and 1.91% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 19.44 million and changing 4.70% at the moment leaves the stock 3.46% off its SMA200. ROIV registered 49.38% gain for a year compared to 6-month gain of -6.51%. The firm has a 50-day simple moving average (SMA 50) of $21.32 and a 200-day simple moving average (SMA200) of $0.61.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -7.22% loss in the last 1 month and extending the period to 3 months gives it a -2.76%, and is 9.75% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.72% over the week and 3.94% over the month.
Roivant Sciences Ltd (ROIV) has around 904 employees, a market worth around $8.80B and $123.24M in sales. Current P/E ratio is 2.10. Profit margin for the company is 3624.14%. Distance from 52-week low is 56.67% and -17.52% from its 52-week high. The company has generated returns on investments over the last 12 months (68.29%).
Roivant Sciences Ltd quarterly earnings per share for the current quarter are estimated at -$0.3 with sales reaching $33.28M over the same period.The EPS is expected to grow by 559.45% this year, but quarterly earnings will post 136.80% year-over-year. Quarterly sales are estimated to grow 21.60% in year-over-year returns.
Roivant Sciences Ltd (ROIV) Top Institutional Holders
311 institutions hold shares in Roivant Sciences Ltd (ROIV), with institutional investors hold 87.90% of the company’s shares. The shares outstanding are 760.14M, and float is at 482.21M with Short Float at 6.55%. Institutions hold 62.06% of the Float.
The top institutional shareholder in the company is QVT Financial LP with over 122.54 million shares valued at $1.24 billion. The investor’s holdings represent 15.88% of the ROIV Shares outstanding. As of Jun 29, 2023, the second largest holder is SB Investment Advisers (UK) LTD with 83.03 million shares valued at $836.96 million to account for 10.76% of the shares outstanding. The other top investors are Viking Global Investors, L.P. which holds 75.24 million shares representing 9.75% and valued at over $758.41 million, while FMR, LLC holds 4.66% of the shares totaling 36.0 million with a market value of $362.85 million.
Roivant Sciences Ltd (ROIV) Insider Activity
The most recent transaction is an insider sale by Venker Eric,the company’sPresident & COO. SEC filings show that Venker Eric sold 96,950 shares of the company’s common stock on Feb 09 ’24 at a price of $10.92 per share for a total of $1.06 million. Following the sale, the insider now owns 0.53 million shares.
Roivant Sciences Ltd disclosed in a document filed with the SEC on Jan 02 ’24 that Ramaswamy Vivek (10% Owner) sold a total of 3,000,000 shares of the company’s common stock. The trade occurred on Jan 02 ’24 and was made at $11.05 per share for $33.15 million. Following the transaction, the insider now directly holds 51.93 million shares of the ROIV stock.
Still, SEC filings show that on Oct 05 ’23, Venker Eric (Chief Operating Officer) disposed off 153,027 shares at an average price of $10.11 for $1.55 million. The insider now directly holds 595,397 shares of Roivant Sciences Ltd (ROIV).
